ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biologics Market Insights, Forecast to 2029
Published Date: August 2023
|
Report Code: QYRE-Auto-18K8726
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
China Biologics Market Report Forecast 2021 2027
BUY CHAPTERS

Global Biologics Market Insights, Forecast to 2029

Code: QYRE-Auto-18K8726
Report
August 2023
Pages:105
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Eli lilly company
Samsung Biologics
F. Hoffman-La Roche
Celltrion
Addgene
Amgen Inc
AbbVie
Sanofi
Pfizer Inc
Merck& Co. Inc
Novo Nordisk A S
Johnson & Johnson Services Inc.

Biologics Market Size

The global Biologics market is projected to grow from US$ 110030 million in 2023 to US$ 149290 million by 2029, at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period.

Biologics Market

Biologics Market

A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA.
North America dominated with respect to revenue generation owing to the presence of significant established participants in this region. Moreover, higher demand for the products for treatment of diseases is attributive for larger revenue share.
In terms of production side, this report researches the Biologics production, growth rate, market share by manufacturers and by region (region level and country level), from 2018 to 2023, and forecast to 2029.
In terms of consumption side, this report focuses on the sales of Biologics by region (region level and country level), by company, by Type and by Application. from 2018 to 2023 and forecast to 2029.

Report Includes:

This report presents an overview of global market for Biologics, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Biologics, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Biologics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Biologics sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Biologics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Biologics sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Eli Lilly & Company, Samsung Biologics, F Hoffman La Roche, Celltrion, Addgene, Amgen, Abbvie Inc., Sanofi and Pfizer Inc., etc.

Scope of Biologics Market Report

Report Metric Details
Report Name Biologics Market
Accounted market size in 2023 US$ 110030 million
Forecasted market size in 2029 US$ 149290 million
CAGR 5.2
Base Year 2023
Forecasted years 2023 - 2029
Segment by Type
  • Monoclonal Antibodies
  • Vaccines
  • Recombinant Proteins
  • Antisense
  • RNAi
Segment by Application
  • Infectious Diseases
  • Oncology
  • Immunology
  • Autoimmune Diseases
Production by Region
  • North America
  • Europe
  • China
  • Japan
Sales by Region
  • US & Canada
  • U.S.
  • Canada
  • China
  • Asia (excluding China)
  • Japan
  • South Korea
  • China Taiwan
  • Southeast Asia
  • India
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Middle East, Africa, Latin America
  • Brazil
  • Mexico
  • Turkey
  • Israel
  • GCC Countries
By Company Eli Lilly & Company, Samsung Biologics, F Hoffman La Roche, Celltrion, Addgene, Amgen, Abbvie Inc., Sanofi, Pfizer Inc., Merck & Co. Inc., Novo Nordisk A/S, Johnson & Johnson Services Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Biologics production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production and development potential of each producer in the next six years.
  • Chapter 3: Sales (consumption), revenue of Biologics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 4: Detailed analysis of Biologics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America (US & Canada) by type, by application and by country, sales and revenue for each segment.
  • Chapter 8: Europe by type, by application and by country, sales and revenue for each segment.
  • Chapter 9: China by type and by application sales and revenue for each segment.
  • Chapter 10: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
  • Chapter 11: Middle East, Africa, Latin America by type, by application and by country, sales and revenue for each segment.
  • Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biologics sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 15: The main points and conclusions of the report.

FAQ for this report

How fast is Biologics Market growing?

Ans: The Biologics Market witnessing a CAGR of 5.2 during the forecast period 2023-2029.

What is the Biologics Market size in 2029?

Ans: The global Biologics market is projected to grow from US$ 110030 million in 2023 to US$ 149290 million by 2029, at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period.

1 Study Coverage
1.1 Biologics Product Introduction
1.2 Market by Type
1.2.1 Global Biologics Market Size by Type, 2018 VS 2022 VS 2029
1.2.2 Monoclonal Antibodies
1.2.3 Vaccines
1.2.4 Recombinant Proteins
1.2.5 Antisense
1.2.6 RNAi
1.3 Market by Application
1.3.1 Global Biologics Market Size by Application, 2018 VS 2022 VS 2029
1.3.2 Infectious Diseases
1.3.3 Oncology
1.3.4 Immunology
1.3.5 Autoimmune Diseases
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Biologics Production
2.1 Global Biologics Production Capacity (2018-2029)
2.2 Global Biologics Production by Region: 2018 VS 2022 VS 2029
2.3 Global Biologics Production by Region
2.3.1 Global Biologics Historic Production by Region (2018-2023)
2.3.2 Global Biologics Forecasted Production by Region (2024-2029)
2.3.3 Global Biologics Production Market Share by Region (2018-2029)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Executive Summary
3.1 Global Biologics Revenue Estimates and Forecasts 2018-2029
3.2 Global Biologics Revenue by Region
3.2.1 Global Biologics Revenue by Region: 2018 VS 2022 VS 2029
3.2.2 Global Biologics Revenue by Region (2018-2023)
3.2.3 Global Biologics Revenue by Region (2024-2029)
3.2.4 Global Biologics Revenue Market Share by Region (2018-2029)
3.3 Global Biologics Sales Estimates and Forecasts 2018-2029
3.4 Global Biologics Sales by Region
3.4.1 Global Biologics Sales by Region: 2018 VS 2022 VS 2029
3.4.2 Global Biologics Sales by Region (2018-2023)
3.4.3 Global Biologics Sales by Region (2024-2029)
3.4.4 Global Biologics Sales Market Share by Region (2018-2029)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufactures
4.1 Global Biologics Sales by Manufacturers
4.1.1 Global Biologics Sales by Manufacturers (2018-2023)
4.1.2 Global Biologics Sales Market Share by Manufacturers (2018-2023)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Biologics in 2022
4.2 Global Biologics Revenue by Manufacturers
4.2.1 Global Biologics Revenue by Manufacturers (2018-2023)
4.2.2 Global Biologics Revenue Market Share by Manufacturers (2018-2023)
4.2.3 Global Top 10 and Top 5 Companies by Biologics Revenue in 2022
4.3 Global Biologics Sales Price by Manufacturers
4.4 Global Key Players of Biologics, Industry Ranking, 2021 VS 2022 VS 2023
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Biologics, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Biologics, Product Offered and Application
4.8 Global Key Manufacturers of Biologics, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Biologics Sales by Type
5.1.1 Global Biologics Historical Sales by Type (2018-2023)
5.1.2 Global Biologics Forecasted Sales by Type (2024-2029)
5.1.3 Global Biologics Sales Market Share by Type (2018-2029)
5.2 Global Biologics Revenue by Type
5.2.1 Global Biologics Historical Revenue by Type (2018-2023)
5.2.2 Global Biologics Forecasted Revenue by Type (2024-2029)
5.2.3 Global Biologics Revenue Market Share by Type (2018-2029)
5.3 Global Biologics Price by Type
5.3.1 Global Biologics Price by Type (2018-2023)
5.3.2 Global Biologics Price Forecast by Type (2024-2029)
6 Market Size by Application
6.1 Global Biologics Sales by Application
6.1.1 Global Biologics Historical Sales by Application (2018-2023)
6.1.2 Global Biologics Forecasted Sales by Application (2024-2029)
6.1.3 Global Biologics Sales Market Share by Application (2018-2029)
6.2 Global Biologics Revenue by Application
6.2.1 Global Biologics Historical Revenue by Application (2018-2023)
6.2.2 Global Biologics Forecasted Revenue by Application (2024-2029)
6.2.3 Global Biologics Revenue Market Share by Application (2018-2029)
6.3 Global Biologics Price by Application
6.3.1 Global Biologics Price by Application (2018-2023)
6.3.2 Global Biologics Price Forecast by Application (2024-2029)
7 US & Canada
7.1 US & Canada Biologics Market Size by Type
7.1.1 US & Canada Biologics Sales by Type (2018-2029)
7.1.2 US & Canada Biologics Revenue by Type (2018-2029)
7.2 US & Canada Biologics Market Size by Application
7.2.1 US & Canada Biologics Sales by Application (2018-2029)
7.2.2 US & Canada Biologics Revenue by Application (2018-2029)
7.3 US & Canada Biologics Sales by Country
7.3.1 US & Canada Biologics Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 US & Canada Biologics Sales by Country (2018-2029)
7.3.3 US & Canada Biologics Revenue by Country (2018-2029)
7.3.4 U.S.
7.3.5 Canada
8 Europe
8.1 Europe Biologics Market Size by Type
8.1.1 Europe Biologics Sales by Type (2018-2029)
8.1.2 Europe Biologics Revenue by Type (2018-2029)
8.2 Europe Biologics Market Size by Application
8.2.1 Europe Biologics Sales by Application (2018-2029)
8.2.2 Europe Biologics Revenue by Application (2018-2029)
8.3 Europe Biologics Sales by Country
8.3.1 Europe Biologics Revenue by Country: 2018 VS 2022 VS 2029
8.3.2 Europe Biologics Sales by Country (2018-2029)
8.3.3 Europe Biologics Revenue by Country (2018-2029)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Biologics Market Size by Type
9.1.1 China Biologics Sales by Type (2018-2029)
9.1.2 China Biologics Revenue by Type (2018-2029)
9.2 China Biologics Market Size by Application
9.2.1 China Biologics Sales by Application (2018-2029)
9.2.2 China Biologics Revenue by Application (2018-2029)
10 Asia (excluding China)
10.1 Asia Biologics Market Size by Type
10.1.1 Asia Biologics Sales by Type (2018-2029)
10.1.2 Asia Biologics Revenue by Type (2018-2029)
10.2 Asia Biologics Market Size by Application
10.2.1 Asia Biologics Sales by Application (2018-2029)
10.2.2 Asia Biologics Revenue by Application (2018-2029)
10.3 Asia Biologics Sales by Region
10.3.1 Asia Biologics Revenue by Region: 2018 VS 2022 VS 2029
10.3.2 Asia Biologics Revenue by Region (2018-2029)
10.3.3 Asia Biologics Sales by Region (2018-2029)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Biologics Market Size by Type
11.1.1 Middle East, Africa and Latin America Biologics Sales by Type (2018-2029)
11.1.2 Middle East, Africa and Latin America Biologics Revenue by Type (2018-2029)
11.2 Middle East, Africa and Latin America Biologics Market Size by Application
11.2.1 Middle East, Africa and Latin America Biologics Sales by Application (2018-2029)
11.2.2 Middle East, Africa and Latin America Biologics Revenue by Application (2018-2029)
11.3 Middle East, Africa and Latin America Biologics Sales by Country
11.3.1 Middle East, Africa and Latin America Biologics Revenue by Country: 2018 VS 2022 VS 2029
11.3.2 Middle East, Africa and Latin America Biologics Revenue by Country (2018-2029)
11.3.3 Middle East, Africa and Latin America Biologics Sales by Country (2018-2029)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profiles
12.1 Eli Lilly & Company
12.1.1 Eli Lilly & Company Company Information
12.1.2 Eli Lilly & Company Overview
12.1.3 Eli Lilly & Company Biologics Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.1.4 Eli Lilly & Company Biologics Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Eli Lilly & Company Recent Developments
12.2 Samsung Biologics
12.2.1 Samsung Biologics Company Information
12.2.2 Samsung Biologics Overview
12.2.3 Samsung Biologics Biologics Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.2.4 Samsung Biologics Biologics Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Samsung Biologics Recent Developments
12.3 F Hoffman La Roche
12.3.1 F Hoffman La Roche Company Information
12.3.2 F Hoffman La Roche Overview
12.3.3 F Hoffman La Roche Biologics Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.3.4 F Hoffman La Roche Biologics Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 F Hoffman La Roche Recent Developments
12.4 Celltrion
12.4.1 Celltrion Company Information
12.4.2 Celltrion Overview
12.4.3 Celltrion Biologics Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.4.4 Celltrion Biologics Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Celltrion Recent Developments
12.5 Addgene
12.5.1 Addgene Company Information
12.5.2 Addgene Overview
12.5.3 Addgene Biologics Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.5.4 Addgene Biologics Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Addgene Recent Developments
12.6 Amgen
12.6.1 Amgen Company Information
12.6.2 Amgen Overview
12.6.3 Amgen Biologics Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.6.4 Amgen Biologics Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Amgen Recent Developments
12.7 Abbvie Inc.
12.7.1 Abbvie Inc. Company Information
12.7.2 Abbvie Inc. Overview
12.7.3 Abbvie Inc. Biologics Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.7.4 Abbvie Inc. Biologics Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Abbvie Inc. Recent Developments
12.8 Sanofi
12.8.1 Sanofi Company Information
12.8.2 Sanofi Overview
12.8.3 Sanofi Biologics Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.8.4 Sanofi Biologics Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Sanofi Recent Developments
12.9 Pfizer Inc.
12.9.1 Pfizer Inc. Company Information
12.9.2 Pfizer Inc. Overview
12.9.3 Pfizer Inc. Biologics Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.9.4 Pfizer Inc. Biologics Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Pfizer Inc. Recent Developments
12.10 Merck & Co. Inc.
12.10.1 Merck & Co. Inc. Company Information
12.10.2 Merck & Co. Inc. Overview
12.10.3 Merck & Co. Inc. Biologics Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.10.4 Merck & Co. Inc. Biologics Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Merck & Co. Inc. Recent Developments
12.11 Novo Nordisk A/S
12.11.1 Novo Nordisk A/S Company Information
12.11.2 Novo Nordisk A/S Overview
12.11.3 Novo Nordisk A/S Biologics Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.11.4 Novo Nordisk A/S Biologics Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Novo Nordisk A/S Recent Developments
12.12 Johnson & Johnson Services Inc.
12.12.1 Johnson & Johnson Services Inc. Company Information
12.12.2 Johnson & Johnson Services Inc. Overview
12.12.3 Johnson & Johnson Services Inc. Biologics Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.12.4 Johnson & Johnson Services Inc. Biologics Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Johnson & Johnson Services Inc. Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Biologics Industry Chain Analysis
13.2 Biologics Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Biologics Production Mode & Process
13.4 Biologics Sales and Marketing
13.4.1 Biologics Sales Channels
13.4.2 Biologics Distributors
13.5 Biologics Customers
14 Biologics Market Dynamics
14.1 Biologics Industry Trends
14.2 Biologics Market Drivers
14.3 Biologics Market Challenges
14.4 Biologics Market Restraints
15 Key Finding in The Global Biologics Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
FEATURED COMPANIES
Eli lilly company
Samsung Biologics
F. Hoffman-La Roche
Celltrion
Addgene
Amgen Inc
AbbVie
Sanofi
Pfizer Inc
Merck& Co. Inc
Novo Nordisk A S
Johnson & Johnson Services Inc.
List of Tables
    Table 1. Global Biologics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
    Table 2. Major Manufacturers of Monoclonal Antibodies
    Table 3. Major Manufacturers of Vaccines
    Table 4. Major Manufacturers of Recombinant Proteins
    Table 5. Major Manufacturers of Antisense
    Table 6. Major Manufacturers of RNAi
    Table 7. Global Biologics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global Biologics Production by Region: 2018 VS 2022 VS 2029 (K MT)
    Table 9. Global Biologics Production by Region (2018-2023) & (K MT)
    Table 10. Global Biologics Production by Region (2024-2029) & (K MT)
    Table 11. Global Biologics Production Market Share by Region (2018-2023)
    Table 12. Global Biologics Production Market Share by Region (2024-2029)
    Table 13. Global Biologics Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 14. Global Biologics Revenue by Region (2018-2023) & (US$ Million)
    Table 15. Global Biologics Revenue by Region (2024-2029) & (US$ Million)
    Table 16. Global Biologics Revenue Market Share by Region (2018-2023)
    Table 17. Global Biologics Revenue Market Share by Region (2024-2029)
    Table 18. Global Biologics Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 19. Global Biologics Sales by Region (2018-2023) & (K MT)
    Table 20. Global Biologics Sales by Region (2024-2029) & (K MT)
    Table 21. Global Biologics Sales Market Share by Region (2018-2023)
    Table 22. Global Biologics Sales Market Share by Region (2024-2029)
    Table 23. Global Biologics Sales by Manufacturers (2018-2023) & (K MT)
    Table 24. Global Biologics Sales Share by Manufacturers (2018-2023)
    Table 25. Global Biologics Revenue by Manufacturers (2018-2023) & (US$ Million)
    Table 26. Global Biologics Revenue Share by Manufacturers (2018-2023)
    Table 27. Biologics Price by Manufacturers 2018-2023 (USD/MT)
    Table 28. Global Key Players of Biologics, Industry Ranking, 2021 VS 2022 VS 2023
    Table 29. Global Biologics Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 30. Global Biologics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics as of 2022)
    Table 31. Global Key Manufacturers of Biologics, Manufacturing Base Distribution and Headquarters
    Table 32. Global Key Manufacturers of Biologics, Product Offered and Application
    Table 33. Global Key Manufacturers of Biologics, Date of Enter into This Industry
    Table 34. Mergers & Acquisitions, Expansion Plans
    Table 35. Global Biologics Sales by Type (2018-2023) & (K MT)
    Table 36. Global Biologics Sales by Type (2024-2029) & (K MT)
    Table 37. Global Biologics Sales Share by Type (2018-2023)
    Table 38. Global Biologics Sales Share by Type (2024-2029)
    Table 39. Global Biologics Revenue by Type (2018-2023) & (US$ Million)
    Table 40. Global Biologics Revenue by Type (2024-2029) & (US$ Million)
    Table 41. Global Biologics Revenue Share by Type (2018-2023)
    Table 42. Global Biologics Revenue Share by Type (2024-2029)
    Table 43. Biologics Price by Type (2018-2023) & (USD/MT)
    Table 44. Global Biologics Price Forecast by Type (2024-2029) & (USD/MT)
    Table 45. Global Biologics Sales by Application (2018-2023) & (K MT)
    Table 46. Global Biologics Sales by Application (2024-2029) & (K MT)
    Table 47. Global Biologics Sales Share by Application (2018-2023)
    Table 48. Global Biologics Sales Share by Application (2024-2029)
    Table 49. Global Biologics Revenue by Application (2018-2023) & (US$ Million)
    Table 50. Global Biologics Revenue by Application (2024-2029) & (US$ Million)
    Table 51. Global Biologics Revenue Share by Application (2018-2023)
    Table 52. Global Biologics Revenue Share by Application (2024-2029)
    Table 53. Biologics Price by Application (2018-2023) & (USD/MT)
    Table 54. Global Biologics Price Forecast by Application (2024-2029) & (USD/MT)
    Table 55. US & Canada Biologics Sales by Type (2018-2023) & (K MT)
    Table 56. US & Canada Biologics Sales by Type (2024-2029) & (K MT)
    Table 57. US & Canada Biologics Revenue by Type (2018-2023) & (US$ Million)
    Table 58. US & Canada Biologics Revenue by Type (2024-2029) & (US$ Million)
    Table 59. US & Canada Biologics Sales by Application (2018-2023) & (K MT)
    Table 60. US & Canada Biologics Sales by Application (2024-2029) & (K MT)
    Table 61. US & Canada Biologics Revenue by Application (2018-2023) & (US$ Million)
    Table 62. US & Canada Biologics Revenue by Application (2024-2029) & (US$ Million)
    Table 63. US & Canada Biologics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 64. US & Canada Biologics Revenue by Country (2018-2023) & (US$ Million)
    Table 65. US & Canada Biologics Revenue by Country (2024-2029) & (US$ Million)
    Table 66. US & Canada Biologics Sales by Country (2018-2023) & (K MT)
    Table 67. US & Canada Biologics Sales by Country (2024-2029) & (K MT)
    Table 68. Europe Biologics Sales by Type (2018-2023) & (K MT)
    Table 69. Europe Biologics Sales by Type (2024-2029) & (K MT)
    Table 70. Europe Biologics Revenue by Type (2018-2023) & (US$ Million)
    Table 71. Europe Biologics Revenue by Type (2024-2029) & (US$ Million)
    Table 72. Europe Biologics Sales by Application (2018-2023) & (K MT)
    Table 73. Europe Biologics Sales by Application (2024-2029) & (K MT)
    Table 74. Europe Biologics Revenue by Application (2018-2023) & (US$ Million)
    Table 75. Europe Biologics Revenue by Application (2024-2029) & (US$ Million)
    Table 76. Europe Biologics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 77. Europe Biologics Revenue by Country (2018-2023) & (US$ Million)
    Table 78. Europe Biologics Revenue by Country (2024-2029) & (US$ Million)
    Table 79. Europe Biologics Sales by Country (2018-2023) & (K MT)
    Table 80. Europe Biologics Sales by Country (2024-2029) & (K MT)
    Table 81. China Biologics Sales by Type (2018-2023) & (K MT)
    Table 82. China Biologics Sales by Type (2024-2029) & (K MT)
    Table 83. China Biologics Revenue by Type (2018-2023) & (US$ Million)
    Table 84. China Biologics Revenue by Type (2024-2029) & (US$ Million)
    Table 85. China Biologics Sales by Application (2018-2023) & (K MT)
    Table 86. China Biologics Sales by Application (2024-2029) & (K MT)
    Table 87. China Biologics Revenue by Application (2018-2023) & (US$ Million)
    Table 88. China Biologics Revenue by Application (2024-2029) & (US$ Million)
    Table 89. Asia Biologics Sales by Type (2018-2023) & (K MT)
    Table 90. Asia Biologics Sales by Type (2024-2029) & (K MT)
    Table 91. Asia Biologics Revenue by Type (2018-2023) & (US$ Million)
    Table 92. Asia Biologics Revenue by Type (2024-2029) & (US$ Million)
    Table 93. Asia Biologics Sales by Application (2018-2023) & (K MT)
    Table 94. Asia Biologics Sales by Application (2024-2029) & (K MT)
    Table 95. Asia Biologics Revenue by Application (2018-2023) & (US$ Million)
    Table 96. Asia Biologics Revenue by Application (2024-2029) & (US$ Million)
    Table 97. Asia Biologics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 98. Asia Biologics Revenue by Region (2018-2023) & (US$ Million)
    Table 99. Asia Biologics Revenue by Region (2024-2029) & (US$ Million)
    Table 100. Asia Biologics Sales by Region (2018-2023) & (K MT)
    Table 101. Asia Biologics Sales by Region (2024-2029) & (K MT)
    Table 102. Middle East, Africa and Latin America Biologics Sales by Type (2018-2023) & (K MT)
    Table 103. Middle East, Africa and Latin America Biologics Sales by Type (2024-2029) & (K MT)
    Table 104. Middle East, Africa and Latin America Biologics Revenue by Type (2018-2023) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Biologics Revenue by Type (2024-2029) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Biologics Sales by Application (2018-2023) & (K MT)
    Table 107. Middle East, Africa and Latin America Biologics Sales by Application (2024-2029) & (K MT)
    Table 108. Middle East, Africa and Latin America Biologics Revenue by Application (2018-2023) & (US$ Million)
    Table 109. Middle East, Africa and Latin America Biologics Revenue by Application (2024-2029) & (US$ Million)
    Table 110. Middle East, Africa and Latin America Biologics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 111. Middle East, Africa and Latin America Biologics Revenue by Country (2018-2023) & (US$ Million)
    Table 112. Middle East, Africa and Latin America Biologics Revenue by Country (2024-2029) & (US$ Million)
    Table 113. Middle East, Africa and Latin America Biologics Sales by Country (2018-2023) & (K MT)
    Table 114. Middle East, Africa and Latin America Biologics Sales by Country (2024-2029) & (K MT)
    Table 115. Eli Lilly & Company Company Information
    Table 116. Eli Lilly & Company Description and Major Businesses
    Table 117. Eli Lilly & Company Biologics Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 118. Eli Lilly & Company Biologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Eli Lilly & Company Recent Development
    Table 120. Samsung Biologics Company Information
    Table 121. Samsung Biologics Description and Major Businesses
    Table 122. Samsung Biologics Biologics Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 123. Samsung Biologics Biologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Samsung Biologics Recent Development
    Table 125. F Hoffman La Roche Company Information
    Table 126. F Hoffman La Roche Description and Major Businesses
    Table 127. F Hoffman La Roche Biologics Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 128. F Hoffman La Roche Biologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. F Hoffman La Roche Recent Development
    Table 130. Celltrion Company Information
    Table 131. Celltrion Description and Major Businesses
    Table 132. Celltrion Biologics Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 133. Celltrion Biologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Celltrion Recent Development
    Table 135. Addgene Company Information
    Table 136. Addgene Description and Major Businesses
    Table 137. Addgene Biologics Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 138. Addgene Biologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Addgene Recent Development
    Table 140. Amgen Company Information
    Table 141. Amgen Description and Major Businesses
    Table 142. Amgen Biologics Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 143. Amgen Biologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Amgen Recent Development
    Table 145. Abbvie Inc. Company Information
    Table 146. Abbvie Inc. Description and Major Businesses
    Table 147. Abbvie Inc. Biologics Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 148. Abbvie Inc. Biologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Abbvie Inc. Recent Development
    Table 150. Sanofi Company Information
    Table 151. Sanofi Description and Major Businesses
    Table 152. Sanofi Biologics Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 153. Sanofi Biologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Sanofi Recent Development
    Table 155. Pfizer Inc. Company Information
    Table 156. Pfizer Inc. Description and Major Businesses
    Table 157. Pfizer Inc. Biologics Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 158. Pfizer Inc. Biologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. Pfizer Inc. Recent Development
    Table 160. Merck & Co. Inc. Company Information
    Table 161. Merck & Co. Inc. Description and Major Businesses
    Table 162. Merck & Co. Inc. Biologics Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 163. Merck & Co. Inc. Biologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 164. Merck & Co. Inc. Recent Development
    Table 165. Novo Nordisk A/S Company Information
    Table 166. Novo Nordisk A/S Description and Major Businesses
    Table 167. Novo Nordisk A/S Biologics Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 168. Novo Nordisk A/S Biologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 169. Novo Nordisk A/S Recent Development
    Table 170. Johnson & Johnson Services Inc. Company Information
    Table 171. Johnson & Johnson Services Inc. Description and Major Businesses
    Table 172. Johnson & Johnson Services Inc. Biologics Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 173. Johnson & Johnson Services Inc. Biologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 174. Johnson & Johnson Services Inc. Recent Development
    Table 175. Key Raw Materials Lists
    Table 176. Raw Materials Key Suppliers Lists
    Table 177. Biologics Distributors List
    Table 178. Biologics Customers List
    Table 179. Biologics Market Trends
    Table 180. Biologics Market Drivers
    Table 181. Biologics Market Challenges
    Table 182. Biologics Market Restraints
    Table 183. Research Programs/Design for This Report
    Table 184. Key Data Information from Secondary Sources
    Table 185. Key Data Information from Primary Sources
List of Figures
    Figure 1. Biologics Product Picture
    Figure 2. Global Biologics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Biologics Market Share by Type in 2022 & 2029
    Figure 4. Monoclonal Antibodies Product Picture
    Figure 5. Vaccines Product Picture
    Figure 6. Recombinant Proteins Product Picture
    Figure 7. Antisense Product Picture
    Figure 8. RNAi Product Picture
    Figure 9. Global Biologics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 10. Global Biologics Market Share by Application in 2022 & 2029
    Figure 11. Infectious Diseases
    Figure 12. Oncology
    Figure 13. Immunology
    Figure 14. Autoimmune Diseases
    Figure 15. Biologics Report Years Considered
    Figure 16. Global Biologics Capacity, Production and Utilization (2018-2029) & (K MT)
    Figure 17. Global Biologics Production Market Share by Region in Percentage: 2022 Versus 2029
    Figure 18. Global Biologics Production Market Share by Region (2018-2029)
    Figure 19. Biologics Production Growth Rate in North America (2018-2029) & (K MT)
    Figure 20. Biologics Production Growth Rate in Europe (2018-2029) & (K MT)
    Figure 21. Biologics Production Growth Rate in China (2018-2029) & (K MT)
    Figure 22. Biologics Production Growth Rate in Japan (2018-2029) & (K MT)
    Figure 23. Global Biologics Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 24. Global Biologics Revenue 2018-2029 (US$ Million)
    Figure 25. Global Biologics Revenue (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Figure 26. Global Biologics Revenue Market Share by Region in Percentage: 2022 Versus 2029
    Figure 27. Global Biologics Revenue Market Share by Region (2018-2029)
    Figure 28. Global Biologics Sales 2018-2029 ((K MT)
    Figure 29. Global Biologics Sales (CAGR) by Region: 2018 VS 2022 VS 2029 (K MT)
    Figure 30. Global Biologics Sales Market Share by Region (2018-2029)
    Figure 31. US & Canada Biologics Sales YoY (2018-2029) & (K MT)
    Figure 32. US & Canada Biologics Revenue YoY (2018-2029) & (US$ Million)
    Figure 33. Europe Biologics Sales YoY (2018-2029) & (K MT)
    Figure 34. Europe Biologics Revenue YoY (2018-2029) & (US$ Million)
    Figure 35. China Biologics Sales YoY (2018-2029) & (K MT)
    Figure 36. China Biologics Revenue YoY (2018-2029) & (US$ Million)
    Figure 37. Asia (excluding China) Biologics Sales YoY (2018-2029) & (K MT)
    Figure 38. Asia (excluding China) Biologics Revenue YoY (2018-2029) & (US$ Million)
    Figure 39. Middle East, Africa and Latin America Biologics Sales YoY (2018-2029) & (K MT)
    Figure 40. Middle East, Africa and Latin America Biologics Revenue YoY (2018-2029) & (US$ Million)
    Figure 41. The Biologics Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
    Figure 42. The Top 5 and 10 Largest Manufacturers of Biologics in the World: Market Share by Biologics Revenue in 2022
    Figure 43. Global Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 44. Global Biologics Sales Market Share by Type (2018-2029)
    Figure 45. Global Biologics Revenue Market Share by Type (2018-2029)
    Figure 46. Global Biologics Sales Market Share by Application (2018-2029)
    Figure 47. Global Biologics Revenue Market Share by Application (2018-2029)
    Figure 48. US & Canada Biologics Sales Market Share by Type (2018-2029)
    Figure 49. US & Canada Biologics Revenue Market Share by Type (2018-2029)
    Figure 50. US & Canada Biologics Sales Market Share by Application (2018-2029)
    Figure 51. US & Canada Biologics Revenue Market Share by Application (2018-2029)
    Figure 52. US & Canada Biologics Revenue Share by Country (2018-2029)
    Figure 53. US & Canada Biologics Sales Share by Country (2018-2029)
    Figure 54. U.S. Biologics Revenue (2018-2029) & (US$ Million)
    Figure 55. Canada Biologics Revenue (2018-2029) & (US$ Million)
    Figure 56. Europe Biologics Sales Market Share by Type (2018-2029)
    Figure 57. Europe Biologics Revenue Market Share by Type (2018-2029)
    Figure 58. Europe Biologics Sales Market Share by Application (2018-2029)
    Figure 59. Europe Biologics Revenue Market Share by Application (2018-2029)
    Figure 60. Europe Biologics Revenue Share by Country (2018-2029)
    Figure 61. Europe Biologics Sales Share by Country (2018-2029)
    Figure 62. Germany Biologics Revenue (2018-2029) & (US$ Million)
    Figure 63. France Biologics Revenue (2018-2029) & (US$ Million)
    Figure 64. U.K. Biologics Revenue (2018-2029) & (US$ Million)
    Figure 65. Italy Biologics Revenue (2018-2029) & (US$ Million)
    Figure 66. Russia Biologics Revenue (2018-2029) & (US$ Million)
    Figure 67. China Biologics Sales Market Share by Type (2018-2029)
    Figure 68. China Biologics Revenue Market Share by Type (2018-2029)
    Figure 69. China Biologics Sales Market Share by Application (2018-2029)
    Figure 70. China Biologics Revenue Market Share by Application (2018-2029)
    Figure 71. Asia Biologics Sales Market Share by Type (2018-2029)
    Figure 72. Asia Biologics Revenue Market Share by Type (2018-2029)
    Figure 73. Asia Biologics Sales Market Share by Application (2018-2029)
    Figure 74. Asia Biologics Revenue Market Share by Application (2018-2029)
    Figure 75. Asia Biologics Revenue Share by Region (2018-2029)
    Figure 76. Asia Biologics Sales Share by Region (2018-2029)
    Figure 77. Japan Biologics Revenue (2018-2029) & (US$ Million)
    Figure 78. South Korea Biologics Revenue (2018-2029) & (US$ Million)
    Figure 79. China Taiwan Biologics Revenue (2018-2029) & (US$ Million)
    Figure 80. Southeast Asia Biologics Revenue (2018-2029) & (US$ Million)
    Figure 81. India Biologics Revenue (2018-2029) & (US$ Million)
    Figure 82. Middle East, Africa and Latin America Biologics Sales Market Share by Type (2018-2029)
    Figure 83. Middle East, Africa and Latin America Biologics Revenue Market Share by Type (2018-2029)
    Figure 84. Middle East, Africa and Latin America Biologics Sales Market Share by Application (2018-2029)
    Figure 85. Middle East, Africa and Latin America Biologics Revenue Market Share by Application (2018-2029)
    Figure 86. Middle East, Africa and Latin America Biologics Revenue Share by Country (2018-2029)
    Figure 87. Middle East, Africa and Latin America Biologics Sales Share by Country (2018-2029)
    Figure 88. Brazil Biologics Revenue (2018-2029) & (US$ Million)
    Figure 89. Mexico Biologics Revenue (2018-2029) & (US$ Million)
    Figure 90. Turkey Biologics Revenue (2018-2029) & (US$ Million)
    Figure 91. Israel Biologics Revenue (2018-2029) & (US$ Million)
    Figure 92. GCC Countries Biologics Revenue (2018-2029) & (US$ Million)
    Figure 93. Biologics Value Chain
    Figure 94. Biologics Production Process
    Figure 95. Channels of Distribution
    Figure 96. Distributors Profiles
    Figure 97. Bottom-up and Top-down Approaches for This Report
    Figure 98. Data Triangulation
    Figure 99. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Microcarrier Bioreactor Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-4O8609
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Immunohistochemistry Reagent Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-25I8231
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global RNA Analysis & Transcriptomic Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-2M4266
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global PCR Tubes And PCR Plates Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-38E8328
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions